City

Boston (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Collaborator

AstraZeneca (1)

Intervention

durvalumab (1)

radiation therapy (1)

tremelimumab (1)

Study Documents

Intervention Type

drug (1)

radiation (1)

Funder Type

Other (1)

Study Type

Interventional (1)

recurrent gynecological cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated

Recurrent Gynecological Cancer
+10 more

Durvalumab
+2 more

Boston, Massachusetts

Martin King

Oct 4, 2022